These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28041629)

  • 1. Prevalence of and outcomes from Staphylococcus aureus pneumonia among hospitalized patients in the United States, 2009-2012.
    Jacobs DM; Shaver A
    Am J Infect Control; 2017 Apr; 45(4):404-409. PubMed ID: 28041629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.
    Shorr AF; Tabak YP; Gupta V; Johannes RS; Liu LZ; Kollef MH
    Crit Care; 2006; 10(3):R97. PubMed ID: 16808853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes.
    Self WH; Wunderink RG; Williams DJ; Zhu Y; Anderson EJ; Balk RA; Fakhran SS; Chappell JD; Casimir G; Courtney DM; Trabue C; Waterer GW; Bramley A; Magill S; Jain S; Edwards KM; Grijalva CG
    Clin Infect Dis; 2016 Aug; 63(3):300-9. PubMed ID: 27161775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Clinical Outcomes and Resource Utilization Associated with Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Infections after Elective Surgery.
    Campbell RS; Emons MF; Mardekian J; Girgenti D; Gaffney M; Yu H
    Surg Infect (Larchmt); 2015 Oct; 16(5):543-52. PubMed ID: 26125541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia--results of a prospective observational study.
    Sicot N; Khanafer N; Meyssonnier V; Dumitrescu O; Tristan A; Bes M; Lina G; Vandenesch F; Vanhems P; Etienne J; Gillet Y
    Clin Microbiol Infect; 2013 Mar; 19(3):E142-8. PubMed ID: 23237492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.
    Rello J; Torres A; Ricart M; Valles J; Gonzalez J; Artigas A; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1545-9. PubMed ID: 7952612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of early and late ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in a trauma population.
    Kashuk JL; Moore EE; Price CS; Zaw-Mon C; Nino T; Haenel J; Biffl WL; Burlew CC; Johnson JL
    J Trauma; 2010 Sep; 69(3):519-22. PubMed ID: 20173657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia.
    Moghnieh R; Alothman AF; Althaqafi AO; Matar MJ; Alenazi TH; Farahat F; Corman SL; Solem CT; Raghubir N; Macahilig C; Stephens JM
    J Infect Public Health; 2017; 10(6):849-854. PubMed ID: 28487208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.
    Lessa FC; Mu Y; Ray SM; Dumyati G; Bulens S; Gorwitz RJ; Fosheim G; DeVries AS; Schaffner W; Nadle J; Gershman K; Fridkin SK; ;
    Clin Infect Dis; 2012 Jul; 55(2):232-41. PubMed ID: 22523264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia.
    Pujol M; Corbella X; Peña C; Pallares R; Dorca J; Verdaguer R; Diaz-Prieto A; Ariza J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):622-8. PubMed ID: 9832263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
    Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
    Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
    Tsuzuki S; Yu J; Matsunaga N; Ohmagari N
    Public Health; 2021 Sep; 198():292-296. PubMed ID: 34507134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological findings of community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus pediatric pneumonia in Hawaii.
    Erdem G; Bergert L; Len K; Melish M; Kon K; DiMauro R
    Pediatr Radiol; 2010 Nov; 40(11):1768-73. PubMed ID: 20467734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia.
    Wooten DA; Winston LG
    Respir Med; 2013 Aug; 107(8):1266-70. PubMed ID: 23756035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of methicillin-resistant and methicillin-susceptible Staphylococcus aureus reveals no clinical and epidemiological but molecular differences.
    Jiménez JN; Ocampo AM; Vanegas JM; Rodriguez EA; Mediavilla JR; Chen L; Muskus CE; Vélez LA; Rojas C; Restrepo AV; Garcés C; Kreiswirth BN; Correa MM
    Int J Med Microbiol; 2013 Mar; 303(2):76-83. PubMed ID: 23369303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia.
    Taneja C; Haque N; Oster G; Shorr AF; Zilber S; Kyan PO; Reyes KC; Moore C; Spalding J; Kothari S; Zervos M
    J Hosp Med; 2010; 5(9):528-34. PubMed ID: 20734457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.